EV/EBITDA Ratio: 74.49x

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 74.49x is 50% below its estimated 1-year average of 148.22x, near the low end of its estimated 1-year range (69.30x–283.35x).

As of 2026-10-05T10:50:31.056Z. 0.34% above its estimated 12-month average of 74.24x.

HNGE EV/EBITDA Ratio Metrics

EV/EBITDA vs. estimated history

At 74.5, EV/EBITDA is at an extreme level, where the multiple carries little signal — higher than 21% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Hinge Health, Inc. (HNGE)?

The EV/EBITDA ratio for HNGE stock is 74.49x.

Is Hinge Health, Inc.'s EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 74.49x is 50% below its estimated 1-year average of 148.22x, near the low end of its estimated 1-year range (69.30x–283.35x).

What is the estimated TTM average EV/EBITDA ratio for Hinge Health, Inc. (HNGE)?

The estimated TTM average EV/EBITDA ratio for HNGE stock is 74.24x.

Related Metrics